Gritstone bio Inc
NASDAQ:GRTS
Gritstone bio Inc
NASDAQ:GRTS
Price:
0.9627 USD
10.66%
Market Closed
Updated:
May 5, 2024
Gritstone bio Inc
Cash from Investing Activities
|
Gritstone bio Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gritstone bio Inc
NASDAQ:GRTS
|
Cash from Investing Activities
$102.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Gritstone bio Inc's Cash from Investing Activities?
Cash from Investing Activities
102.3m
USD
102.3m
USD
Based on the financial report for Dec 31, 2023, Gritstone bio Inc's Cash from Investing Activities amounts to 102.3m USD.
What is Gritstone bio Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 3Y
16%
16%
The average annual Cash from Investing Activities growth rates for Gritstone bio Inc have been 16% over the past three years .
You don't have any saved screeners yet
